X

Brawn Biotech Ltd. Stock Analysis

Small Cap
Evaluated by 207 users | BSE: 530207 | NSE: |
Trading
Brawn Pharmaceuticals was incorporated in the year 1985 it operates in health care sector in India and outside India. It has started its business by selling pharmaceutical formulations manufactured by other company’s loan license basis. The company is located in New Delhi,...

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19
Return on Capital Employed 13.02%6%1.4%9.26%6.33%7.45%19.89%16.55%17.8%15.86%
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 116.115.125.937.838.746.960.655.865.2
Y-o-Y Gr. Rt.-1597.9%-6.6%71.9%45.9%2.3%21.3%29.2%-7.9%16.9%
Adjusted EPS (Rs.) 1.610.710.081.170.640.963.33.314.184.14
Y-o-Y Gr. Rt.--55.9%-88.7%1362.5%-45.3%50%243.8%0.3%26.3%-1%
Book Value per Share (Rs.) 13.1513.8613.9415.1215.616.4618.4223.0625.4328.85
Adjusted Net Profit 0.50.200.40.20.3111.31.2
Net Op. Cash Flow (Rs. Cr.) 00.20.10.10.20.20.11.4-1.50.2
Debt to Cash Flow from Ops 000.180.260.030.482.38000
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Brawn Biotech Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales 60%11.5%11.6%16.9%
Adjusted EPS 11.1%45.3%7.9%-1%
Book Value per Share 9.113.116.113.5
Share Price 13.9% -3.5% -24.7% -12.7%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19
Return on Equity (%) 135.270.568.034.196.0218.9115.9417.2415.26
Operating Profit Margin (%) -19.122.821.732.431.191.473.192.063.511.8
Net Profit Margin (%) 50.531.320.151.350.510.752.111.642.251.91
Debt to Equity 000.01000.020.02000
Working Capital Days 1,47814926117912912710585120122
Cash Conversion Cycle 1,192564223272828313227
Entity Percentage Holding
Promoters 53.71%
Institutions 0.59%
Non-Institutions 45.69%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

The 5-year analysis of Brawn Biotech's performance infers:

Brawn Biotech earnings have grown by 45.3%, whereas share price has depreciated -3.5% CAGR over the past five years, indicating the company's share price is likely undervalued. However, for specific investment actions please connect with your investment advisor.

We analysed the performance of Brawn Biotech share prices over the last 10 years. Here is what we found out:

Brawn Biotech share price has depreciated 4.2% annually over the past ten years.

Brawn Pharmaceuticals was incorporated in the year 1985 it operates in health care sector in India and outside India. It has started its business by selling pharmaceutical formulations manufactured by other company’s loan license basis. The company is located in New Delhi, India.

Business Profile:

The company involves in the manufacture, contract manufacture, and supply of pharmaceutical products. It is basically

Brawn Pharmaceuticals was incorporated in the year 1985 it operates in health care sector in India and outside India. It has started its business by selling pharmaceutical formulations manufactured by other company’s loan license basis. The company is located in New Delhi, India.

Business Profile:

The company involves in the manufacture, contract manufacture, and supply of pharmaceutical products. It is basically engages in the manufacture of tablets, capsules, and oral syrups.

Products of the company

Company's products are made under various categories namely Analgesics, Antibiotics, Anti Tuberculosis, Anti-inflammatory, Antipyretic, Anti Malarial, B Complex and Amino Acids, Cardiovascular drugs, Antiphyscotropic drugs, Tranquilizers, Antacids.

Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback